Goldman Sachs’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,191,359
| Closed | -$4.89M | – | 6005 |
|
|
2022
Q1 | $4.89M | Buy |
1,191,359
+51,656
| +5% | +$212K | ﹤0.01% | 2821 |
|
|
2021
Q4 | $4.07M | Buy |
1,139,703
+713,905
| +168% | +$2.55M | ﹤0.01% | 2960 |
|
|
2021
Q3 | $1.55M | Buy |
425,798
+55,818
| +15% | +$203K | ﹤0.01% | 3671 |
|
|
2021
Q2 | $1.61M | Buy |
369,980
+103,472
| +39% | +$451K | ﹤0.01% | 3673 |
|
|
2021
Q1 | $1.1M | Sell |
266,508
-519,450
| -66% | -$2.13M | ﹤0.01% | 3838 |
|
|
2020
Q4 | $3.14M | Sell |
785,958
-174,073
| -18% | -$695K | ﹤0.01% | 2784 |
|
|
2020
Q3 | $2.59M | Buy |
960,031
+129,722
| +16% | +$350K | ﹤0.01% | 2763 |
|
|
2020
Q2 | $2.28M | Buy |
830,309
+247,842
| +43% | +$681K | ﹤0.01% | 2774 |
|
|
2020
Q1 | $1.37M | Sell |
582,467
-499,013
| -46% | -$1.18M | ﹤0.01% | 2952 |
|
|
2019
Q4 | $5.08M | Buy |
1,081,480
+734,783
| +212% | +$3.45M | ﹤0.01% | 2417 |
|
|
2019
Q3 | $1.16M | Buy |
346,697
+176,112
| +103% | +$589K | ﹤0.01% | 3164 |
|
|
2019
Q2 | $562K | Sell |
170,585
-167,100
| -49% | -$551K | ﹤0.01% | 3472 |
|
|
2019
Q1 | $1.02M | Buy |
337,685
+203,492
| +152% | +$616K | ﹤0.01% | 3246 |
|
|
2018
Q4 | $365K | Buy |
134,193
+32,740
| +32% | +$89.1K | ﹤0.01% | 3532 |
|
|
2018
Q3 | $341K | Sell |
101,453
-5,590
| -5% | -$18.8K | ﹤0.01% | 3616 |
|
|
2018
Q2 | $277K | Sell |
107,043
-16,468
| -13% | -$42.6K | ﹤0.01% | 3759 |
|
|
2018
Q1 | $271K | Sell |
123,511
-5,959
| -5% | -$13.1K | ﹤0.01% | 3733 |
|
|
2017
Q4 | $257K | Sell |
129,470
-205,037
| -61% | -$407K | ﹤0.01% | 3720 |
|
|
2017
Q3 | $1.08M | Sell |
334,507
-45,135
| -12% | -$146K | ﹤0.01% | 3183 |
|
|
2017
Q2 | $1.22M | Sell |
379,642
-197,022
| -34% | -$634K | ﹤0.01% | 3055 |
|
|
2017
Q1 | $1.64M | Buy |
576,664
+445,009
| +338% | +$1.26M | ﹤0.01% | 2852 |
|
|
2016
Q4 | $307K | Sell |
131,655
-174,847
| -57% | -$408K | ﹤0.01% | 3702 |
|
|
2016
Q3 | $515K | Buy |
306,502
+8,587
| +3% | +$14.4K | ﹤0.01% | 3422 |
|
|
2016
Q2 | $313K | Buy |
297,915
+275,007
| +1,200% | +$289K | ﹤0.01% | 3602 |
|
|
2016
Q1 | $20K | Sell |
22,908
-97,151
| -81% | -$84.8K | ﹤0.01% | 4374 |
|
|
2015
Q4 | $145K | Sell |
120,059
-28,476
| -19% | -$34.4K | ﹤0.01% | 3860 |
|
|
2015
Q3 | $253K | Buy |
148,535
+77,967
| +110% | +$133K | ﹤0.01% | 3706 |
|
|
2015
Q2 | $147K | Buy |
70,568
+5,973
| +9% | +$12.4K | ﹤0.01% | 4162 |
|
|
2015
Q1 | $175K | Sell |
64,595
-35,087
| -35% | -$95.1K | ﹤0.01% | 3951 |
|
|
2014
Q4 | $256K | Buy |
99,682
+4,028
| +4% | +$10.3K | ﹤0.01% | 3810 |
|
|
2014
Q3 | $175K | Buy |
95,654
+3,348
| +4% | +$6.13K | ﹤0.01% | 4020 |
|
|
2014
Q2 | $246K | Sell |
92,306
-6,236
| -6% | -$16.6K | ﹤0.01% | 3846 |
|
|
2014
Q1 | $345K | Sell |
98,542
-32,436
| -25% | -$114K | ﹤0.01% | 3598 |
|
|
2013
Q4 | $586K | Buy |
130,978
+46,151
| +54% | +$206K | ﹤0.01% | 3342 |
|
|
2013
Q3 | $344K | Buy |
84,827
+15,550
| +22% | +$63.1K | ﹤0.01% | 3541 |
|
|
2013
Q2 | $288K | Buy |
+69,277
| New | +$288K | ﹤0.01% | 3452 |
|